{"schema_version":"1","generated_at":"2026-11-06T03:21:47.077Z","data_as_of":null,"url":"https://www.findmykol.com/kol/abdul-miah","json_url":"https://www.findmykol.com/kol/abdul-miah/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"abdul-miah","name":"Abdul Miah","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The Ohio State University Comprehensive Cancer Center","institution_url":"https://www.findmykol.com/institution/the-ohio-state-university","city":"Mooresville","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1467848010","orcid":"0000-0003-4179-6036","openalex":"A5006900391"},"summary":"Abdul Miah is an Oncology physician affiliated with The Ohio State University Comprehensive Cancer Center. OpenAlex indexes 47 publications with 377 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":47,"cited_by_count":377,"h_index":11,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":19,"program_years":{"first":2021,"last":null},"rows_total":21,"shown":3,"withheld":18,"rows":[{"payer":"SANOFI-AVENTIS U.S. LLC","program_year":2025,"amount_usd":120.79,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1467848010"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":81.06,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1467848010"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":79.72,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1467848010"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1467848010","source":"payments"},"prescribing":{"data_year":2020,"areas_total":1,"areas_shown":1,"areas":[{"area":"Blood & clotting","share_pct":100,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":100,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2020,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":47,"shown":5,"withheld":42,"matched_by":"OpenAlex author record","recent":[{"title":"Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome–immune cell signatures","year":2026,"journal":"Cancer Immunology Immunotherapy","source_url":"https://doi.org/10.1007/s00262-026-04346-7","status":"verified"},{"title":"Changes in Glucose level During Chemotherapy Treatment in Patients With Stage I–IV Breast Cancer","year":2025,"journal":"Clinical Breast Cancer","source_url":"https://doi.org/10.1016/j.clbc.2025.05.021","status":"verified"},{"title":"Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy","year":2023,"journal":"Cancer Immunology Immunotherapy","source_url":"https://doi.org/10.1007/s00262-023-03392-9","status":"verified"},{"title":"The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer","year":2023,"journal":"Oncology and Therapy","source_url":"https://doi.org/10.1007/s40487-023-00235-6","status":"verified"},{"title":"Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival","year":2022,"journal":"Journal of Cancer Research and Clinical Oncology","source_url":"https://doi.org/10.1007/s00432-022-04340-3","status":"verified"}],"source":"works"},"contact":{"address_1":"146 MEDICAL PARK RD STE 212","city":"Mooresville","state":"NC","zip":"281178529","phone":"704-659-7850","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1467848010","source":"identity"},"similar":[{"name":"Ricardo Carrau","slug":"ricardo-carrau","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Otolaryngology","url":"https://www.findmykol.com/kol/ricardo-carrau","json_url":"https://www.findmykol.com/kol/ricardo-carrau/profile.json"},{"name":"Gregory Otterson","slug":"gregory-otterson","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gregory-otterson","json_url":"https://www.findmykol.com/kol/gregory-otterson/profile.json"},{"name":"Raphael Pollock","slug":"raphael-pollock","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/raphael-pollock","json_url":"https://www.findmykol.com/kol/raphael-pollock/profile.json"},{"name":"Steven Clinton","slug":"steven-clinton","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/steven-clinton","json_url":"https://www.findmykol.com/kol/steven-clinton/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":18,"publications":42}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-05-29","provider_certified":"2026-05-29","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020}},"methodology_url":"https://www.findmykol.com/about#methodology"}